119 related articles for article (PubMed ID: 3736410)
1. Low density lipoprotein metabolism in familial combined hyperlipidemia and familial hypercholesterolemia: kinetic analysis using an integrated model.
Chait A; Foster DM; Albers JJ; Failor RA; Brunzell JD
Metabolism; 1986 Aug; 35(8):697-704. PubMed ID: 3736410
[TBL] [Abstract][Full Text] [Related]
2. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
Kissebah AH; Alfarsi S; Evans DJ
Arteriosclerosis; 1984; 4(6):614-24. PubMed ID: 6508636
[TBL] [Abstract][Full Text] [Related]
3. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
Kissebah AH; Alfarsi S; Adams PW
Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
[TBL] [Abstract][Full Text] [Related]
4. Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Brunzell JD; Chait A; Albers JJ; Foster DM; Failor RA; Bierman EL
Am Heart J; 1987 Feb; 113(2 Pt 2):583-8. PubMed ID: 3812212
[TBL] [Abstract][Full Text] [Related]
5. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
Teng B; Sniderman AD; Soutar AK; Thompson GR
J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy.
Ericsson S; Eriksson M; Berglund L; Angelin B
J Intern Med; 1992 Oct; 232(4):313-20. PubMed ID: 1402634
[TBL] [Abstract][Full Text] [Related]
7. Evidence for kinetic heterogeneity among human low density lipoproteins.
Foster DM; Chait A; Albers JJ; Failor RA; Harris C; Brunzell JD
Metabolism; 1986 Aug; 35(8):685-96. PubMed ID: 3736409
[TBL] [Abstract][Full Text] [Related]
8. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
Fisher WR; Zech LA; Stacpoole PW
Arterioscler Thromb; 1994 Apr; 14(4):501-10. PubMed ID: 8148348
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein-apolipoprotein B metabolism following apheresis: simulation studies of mass changes and tracer kinetics.
Barrett PH; Parhofer KG
Metabolism; 1998 Apr; 47(4):478-83. PubMed ID: 9550549
[TBL] [Abstract][Full Text] [Related]
10. Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects.
Janus ED; Nicoll AM; Turner PR; Magill P; Lewis B
Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):161-72. PubMed ID: 6780364
[TBL] [Abstract][Full Text] [Related]
11. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
[TBL] [Abstract][Full Text] [Related]
12. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
Rader DJ; Mann WA; Cain W; Kraft HG; Usher D; Zech LA; Hoeg JM; Davignon J; Lupien P; Grossman M
J Clin Invest; 1995 Mar; 95(3):1403-8. PubMed ID: 7883987
[TBL] [Abstract][Full Text] [Related]
13. Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects.
Knight BL; Perombelon YF; Soutar AK; Wade DP; Seed M
Atherosclerosis; 1991 Apr; 87(2-3):227-37. PubMed ID: 1830206
[TBL] [Abstract][Full Text] [Related]
14. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
15. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
Gaffney D; Forster L; Caslake MJ; Bedford D; Stewart JP; Stewart G; Wieringa G; Dominiczak M; Miller JP; Packard CJ
Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
[TBL] [Abstract][Full Text] [Related]
16. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.
Bilheimer DW; Stone NJ; Grundy SM
J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811
[TBL] [Abstract][Full Text] [Related]
17. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
[TBL] [Abstract][Full Text] [Related]
18. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight.
Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Perez-Calahorra S; Bea AM; Marco-Benedí V; Jarauta E; Mateo-Gallego R; Civeira F
J Nutr Biochem; 2018 Mar; 53():48-57. PubMed ID: 29190549
[TBL] [Abstract][Full Text] [Related]
20. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.
Schonfeld G; Aguilar-Salina C; Elias N
Am J Cardiol; 1998 Feb; 81(4A):43B-46B. PubMed ID: 9526813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
